Unmet device reprogramming needs at the end of life among patients with implantable cardioverter defibrillator: A systematic review and meta-analysis.

CONCLUSIONS: The prevalence of implantable cardioverter defibrillator reprogramming and advance directives that explicitly mentioned the device was very low. Study data suggested reprogramming decisions were made very late, after the patient experienced multiple shocks. Patient suffering could be ameliorated if physicians and other healthcare professionals adhere to clinical guidelines for the good management of the device at the end of life and include deactivating the shock function in the discussion that leads to the advance directive.
PMID: 32588755 [PubMed - as supplied by publisher]

Source: Palliative Medicine - June 25, 2020 Category: Palliative Care Authors: Gonzalez-Jaramillo V, Sobanski P, Calvache JA, Arenas-Ochoa LF, Franco OH, Hunziker L, Eychmüller S, Maessen M Tags: Palliat Med Source Type: research